Cooper Companies Net Interest Income Over Time
| COO Stock | USD 81.57 0.09 0.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cooper Companies Performance and Cooper Companies Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Cooper diversify its offerings? Factors like these will boost the valuation of Cooper Companies. Projected growth potential of Cooper fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cooper Companies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.28) | Earnings Share 1.88 | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets |
Investors evaluate Cooper Companies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cooper Companies' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cooper Companies' market price to deviate significantly from intrinsic value.
It's important to distinguish between Cooper Companies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cooper Companies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cooper Companies' market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Interest Income Analysis
Compare Cooper Companies and related stocks such as Neurocrine Biosciences, Hologic, and ICON PLC Net Interest Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | (19.5 M) | (30.5 M) | (32 M) | (32.8 M) | (25.8 M) | (7.1 M) | (4.6 M) | 91 M | 104.7 M | 109.9 M |
| HOLX | (154.6 M) | (154.6 M) | (154.6 M) | (154.6 M) | (154.6 M) | (154.6 M) | (149.4 M) | (142.4 M) | (136.2 M) | (112.2 M) | (92.2 M) | (82.2 M) | 9.4 M | (13.4 M) | (42.7 M) | (49.1 M) | (51.6 M) |
| ICLR | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (10.3 M) | (8.7 M) | (6.4 M) | (10.3 M) | (181.8 M) | (227.4 M) | (331.7 M) | (228.6 M) | (205.8 M) | (195.5 M) |
| UHS | (116.6 M) | (116.6 M) | (116.6 M) | (116.6 M) | (116.6 M) | (116.6 M) | (116.6 M) | (142.8 M) | (161.7 M) | (166.1 M) | (106.3 M) | (83.7 M) | (126.9 M) | (197 M) | (186.1 M) | (167.5 M) | (175.9 M) |
| TEM | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (14.6 M) | (18.9 M) | (39.3 M) | (42.6 M) | (38.3 M) | (40.2 M) |
| SNN | (62 M) | (62 M) | (62 M) | (62 M) | (62 M) | (62 M) | (62 M) | (61 M) | (71 M) | (73 M) | (63 M) | (91 M) | (74 M) | (105 M) | (149 M) | (134.1 M) | (127.4 M) |
| SOLV | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (367 M) | (330.3 M) | (313.8 M) |
| SMMT | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | 2.7 M | 3.1 M | (251 K) | (251 K) | (281 K) | (4.4 M) | (6.1 M) | 4.8 M | 4.3 M | 4.5 M |
| FMS | (385.6 M) | (385.6 M) | (385.6 M) | (385.6 M) | (385.6 M) | (385.6 M) | (385.6 M) | (353.9 M) | (301.1 M) | (429.4 M) | (368 M) | (280 M) | (292 M) | (336.4 M) | (335.5 M) | (385.8 M) | (405.1 M) |
| DOCS | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.5 M | 301 K | 2.1 M | 9.3 M | 21.7 M | 35.9 M | 41.2 M | 43.3 M |
Cooper Companies and related stocks such as Neurocrine Biosciences, Hologic, and ICON PLC Net Interest Income description
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.My Equities
My Current Equities and Potential Positions
| The Cooper Companies | COO |
| Classification | Obamacare Repeal |
| Business Address | 6101 Bollinger Canyon |
| Exchange | NASDAQ Exchange |
USD 81.57
Check out Cooper Companies Performance and Cooper Companies Correlation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Cooper Companies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.